90 related articles for article (PubMed ID: 9382540)
1. [Clinical efficacy of post-TUR prophylactic chemotherapy for superficial bladder cancer--the result of co-operative prospective randomized trial].
Takahashi Y; Kuriyama M; Yamada S; Fujimoto Y; Takeuchi T; Doi T; Sakai S; Isogai K; Kanematsu M; Hayashi H; Fujihiro S; Hasegawa Y; Ehara H; Maeda S; Itoh F; Kobayashi S; Horie M; Matsuda S; Takeda A; Tei KH; Kawada Y
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1817-9. PubMed ID: 9382540
[TBL] [Abstract][Full Text] [Related]
2. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430
[TBL] [Abstract][Full Text] [Related]
3. [Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules].
Segawa N; Nishida T; Takahara K; Nomi H; Azuma H; Katsuoka Y
Hinyokika Kiyo; 2008 Nov; 54(11):711-6. PubMed ID: 19068724
[TBL] [Abstract][Full Text] [Related]
4. Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30mg/40ml, 40mg/40ml.
Kuroda M; Niijima T; Kotake T; Akaza H; Hinotsu S;
Eur Urol; 2004 May; 45(5):600-5. PubMed ID: 15082202
[TBL] [Abstract][Full Text] [Related]
5. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
Hinotsu S; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T; Obata K; Ohashi Y; Ohe H; Shimazaki J; Tashiro K;
Gan To Kagaku Ryoho; 2002 Jan; 29(1):73-80. PubMed ID: 11816482
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
[TBL] [Abstract][Full Text] [Related]
7. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of different dosages of intravesical epirubicin instillation for prevention of primary superficial bladder carcinoma from recurrence].
Wu ZB; Lin GB; Chen BJ; Wu ZM; Rong RM
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):507-9. PubMed ID: 16188156
[TBL] [Abstract][Full Text] [Related]
9. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
Mitsumori K; Tsuchiya N; Habuchi T; Li Z; Akao T; Ohyama C; Sato K; Kato T
BJU Int; 2004 Aug; 94(3):317-21. PubMed ID: 15291859
[TBL] [Abstract][Full Text] [Related]
10. [Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time].
Nonomura N; Nishimura K; Okuyama A; Miki T; Kishimoto T; Kiyohara H; Wakatsuki A; Fujioka H; Kuroda H; Nakano E; Takeyama M; Koide T; Yamaguchi S
Hinyokika Kiyo; 2001 May; 47(5):315-9. PubMed ID: 11433751
[TBL] [Abstract][Full Text] [Related]
11. Intravesical epirubicin treatment following TUR in superficial bladder tumours.
Imamoğlu MA; Bakirtaş H; Yiğitbaşi O; Ersoy H; Sertçelik AN
Arch Esp Urol; 2001 Dec; 54(10):1147-53. PubMed ID: 11852530
[TBL] [Abstract][Full Text] [Related]
12. Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
Liu B; Wang Z; Chen B; Yu J; Zhang P; Ding Q; Zhang Y
Cancer Invest; 2006 Mar; 24(2):160-3. PubMed ID: 16537185
[TBL] [Abstract][Full Text] [Related]
13. [Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study].
Maekawa S; Suzuki H; Ohkubo K; Aoki Y; Okada T; Maeda H; Ogura K; Arai Y
Hinyokika Kiyo; 2000 May; 46(5):301-6. PubMed ID: 10876750
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
15. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences.
Berrum-Svennung I; Granfors T; Jahnson S; Boman H; Holmäng S
J Urol; 2008 Jan; 179(1):101-5; discussion 105-6. PubMed ID: 17997459
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of single early instillation of (2"R)-4'-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma.
Okamura K; Ono Y; Kinukawa T; Matsuura O; Yamada S; Ando T; Fukatsu T; Ohno Y; Ohshima S;
Cancer; 2002 May; 94(9):2363-8. PubMed ID: 12015761
[TBL] [Abstract][Full Text] [Related]
17. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
Gudjónsson S; Adell L; Merdasa F; Olsson R; Larsson B; Davidsson T; Richthoff J; Hagberg G; Grabe M; Bendahl PO; Månsson W; Liedberg F
Eur Urol; 2009 Apr; 55(4):773-80. PubMed ID: 19153001
[TBL] [Abstract][Full Text] [Related]
18. [Effect of prophylactic treatment with intravesical epirubicin in recurrence of superficial bladder tumor].
Pérez Mestre M; Cuñat Albert E; Francisco Mingol V; Arrufat Boix JM; Gallego Gómez J
Arch Esp Urol; 1999 May; 52(4):345-50. PubMed ID: 10380324
[TBL] [Abstract][Full Text] [Related]
19. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
Hinotsu S; Akaza H; Ohashi Y; Kotake T
Cancer; 1999 Nov; 86(9):1818-26. PubMed ID: 10547556
[TBL] [Abstract][Full Text] [Related]
20. Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C.
Stoehr B; Mueller T; Granig T; Zangerl F; Steiner H
BJU Int; 2008 Dec; 102(11):1556-9. PubMed ID: 18691179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
